319 related articles for article (PubMed ID: 17367769)
1. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
Fiegenbaum M; de Andrade FM; Hutz MH
Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
[TBL] [Abstract][Full Text] [Related]
2. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
Tarr PE; Taffé P; Bleiber G; Furrer H; Rotger M; Martinez R; Hirschel B; Battegay M; Weber R; Vernazza P; Bernasconi E; Darioli R; Rickenbach M; Ledergerber B; Telenti A;
J Infect Dis; 2005 May; 191(9):1419-26. PubMed ID: 15809899
[TBL] [Abstract][Full Text] [Related]
3. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status.
Peacock RE; Temple A; Gudnason V; Rosseneu M; Humphries SE
Genet Epidemiol; 1997; 14(3):265-82. PubMed ID: 9181356
[TBL] [Abstract][Full Text] [Related]
4. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
Petrovic D; Zorc M; Peterlin B
Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
[TBL] [Abstract][Full Text] [Related]
5. Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy.
Ng MC; Baum L; So WY; Lam VK; Wang Y; Poon E; Tomlinson B; Cheng S; Lindpaintner K; Chan JC
Clin Genet; 2006 Jul; 70(1):20-8. PubMed ID: 16813599
[TBL] [Abstract][Full Text] [Related]
6. [Interaction of ApoE and LDL-R gene polymorphisms and alcohol drinking and smoking on coronary heart disease].
Wang CH; Zhou X; Zhou GD; Han DF; Zheng F
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):554-8. PubMed ID: 15144588
[TBL] [Abstract][Full Text] [Related]
7. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters.
Jemaa R; Elasmi M; Naouali C; Feki M; Kallel A; Souissi M; Sanhaji H; Hadj Taïeb S; Souheil O; Kaabachi N
Clin Biochem; 2006 Aug; 39(8):816-20. PubMed ID: 16714010
[TBL] [Abstract][Full Text] [Related]
9. Interactions of functional apolipoprotein E gene promoter polymorphisms with smoking on aortic atherosclerosis.
Viiri LE; Viiri KM; Ilveskoski E; Huhtala H; Mäki M; Tienari PJ; Perola M; Lehtimäki T; Karhunen PJ
Circ Cardiovasc Genet; 2008 Dec; 1(2):107-16. PubMed ID: 20031552
[TBL] [Abstract][Full Text] [Related]
10. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.
Raygani AV; Rahimi Z; Kharazi H; Tavilani H; Pourmotabbed T
Neurosci Lett; 2006 Nov; 408(1):68-72. PubMed ID: 16997467
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
Duman BS; Oztürk M; Yilmazer S; Hatemi H
Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
[TBL] [Abstract][Full Text] [Related]
12. Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men.
Waterworth DM; Talmud PJ; Bujac SR; Fisher RM; Miller GJ; Humphries SE
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2663-9. PubMed ID: 11116069
[TBL] [Abstract][Full Text] [Related]
13. The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe.
Haddy N; De Bacquer D; Chemaly MM; Maurice M; Ehnholm C; Evans A; Sans S; Do Carmo Martins M; De Backer G; Siest G; Visvikis S
Eur J Hum Genet; 2002 Dec; 10(12):841-50. PubMed ID: 12461692
[TBL] [Abstract][Full Text] [Related]
14. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
Wang C; Zhou X; Ye S; Han D; Tan X; Zheng F; Shi Q
Int J Hyg Environ Health; 2006 May; 209(3):265-73. PubMed ID: 16459141
[TBL] [Abstract][Full Text] [Related]
15. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
[TBL] [Abstract][Full Text] [Related]
16. Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.
Peter A; Kantartzis K; Machicao F; Machann J; Wagner S; Templin S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
Int J Obes (Lond); 2012 Jun; 36(6):774-82. PubMed ID: 21829161
[TBL] [Abstract][Full Text] [Related]
17. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects.
Fiegenbaum M; da Silveira FR; Van der Sand CR; Van der Sand LC; Ferreira ME; Pires RC; Hutz MH
Clin Chim Acta; 2005 Dec; 362(1-2):182-8. PubMed ID: 16038892
[TBL] [Abstract][Full Text] [Related]
20. Context-dependent and invariant associations between APOE genotype and levels of lipoproteins and risk of ischemic heart disease: a review.
Frikke-Schmidt R
Scand J Clin Lab Invest Suppl; 2000; 233():3-25. PubMed ID: 11317940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
